Xylem
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 3 weeks.
- Its last 4 Sell calls were actually followed by a +4% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -23.4% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 3.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-21 20:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation B
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 21.0x | Better than 40% |
| Forward P/E | 20.0x | Better than 36% |
| Price / Sales | 2.4x | Better than 51% |
| P/E vs own 5-yr range | 1st pctl | Better than 99% |
Growth A
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 17.8% | Better than 80% |
| Net income CAGR (3Y) | 39.2% | Better than 85% |
| Free cash flow CAGR (3Y) | 32.9% | Better than 76% |
Profitability B-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 38.5% | Better than 46% |
| Operating margin | 14.7% | Better than 64% |
| Net margin | 10.6% | Better than 61% |
| Return on equity | 8.7% | Better than 47% |
| Return on invested capital | 7.3% | Better than 57% |
Momentum C-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -16.2% | Better than 37% |
| 6-month return | -13.5% | Better than 34% |
| 12-month return (ex latest month) | -21.1% | Better than 14% |
| Distance below 52-week high | 34.7% | Better than 35% |
Financial Health B+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.6x | Better than 46% |
| Debt to assets | 11.7% | Better than 67% |
| Interest coverage | 41.7x | Better than 89% |
| Free cash flow / net income | 95.1% | Better than 35% |
Analyst View C
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 50.0% | Better than 26% |
| Upside to average target | 24.7% | Better than 41% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 95.24
- Open
- 96.00
- Day range
- 94.19 - 97.57
- Avg price
- 95.18
- Volume
- 3.00M
- Turnover
- 285.54M
- Turnover ratei
- 1.31%
- Volume ratioi
- 1.27
- Amplitudei
- 3.55%
- 52-week rangei
- 87.40 - 144.93
Valuation
- P/Ei
- 24.15
- P/E (TTM)i
- 20.99
- P/Bi
- 2.11
- EPSi
- 3.92
- Book value / shi
- 44.78
- Net profit
- 898.99M
- Net assets
- 10.27B
Share structure
- Market cap
- 21.71B
- Float capi
- 21.64B
- Shares out
- 229.33M
- Float sharesi
- 228.61M
Dividend & listing
- Div yield (TTM)i
- 1.79%
- Dividend (TTM)
- 1.69
- Listing date
- 1970-01-01
34.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-125.05M net over the window
Short interest
- Shares short
- 8.66M
- % of floati
- 3.78%
- Days to coveri
- 2.11
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Xylem (XYL)?
Xylem last traded at 94.66. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Xylem's market cap?
About 21.71B.
What is the P/E ratio of Xylem?
The trailing twelve-month P/E is 20.99, below its own 5-year average of 40.73 — toward the bottom of its historical range (0.64% percentile). See the Valuation tab for the full history.
Does Xylem pay a dividend?
Yes. The trailing dividend yield is 1.79%. The 2025 payout was up 11.1% from 2024. See the Dividends tab for the full payment history.
Is Xylem a buy according to analysts?
The consensus of 14 analysts is a Buy rating, with an average 12-month price target of 118.08, which implies 24.7% upside from the current price. This is not investment advice.
What is Xylem's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Xylem a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-11-20 19:33:55 · For reference only, not investment advice and not tailored to your situation.
Xylem discussion 0 comments